Weekly Digest – April 2024 Weekly Digest – April 2024 9 Apr 2024: BioCity’s first-in-class ADC targeting Glypican 3 clears FDA’s IND application BioCity Biopharma gains FDA clearance for Phase 1 study of BC2027, a first-in-class ADC targeting Glypican 3 […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id